Medical Devices News

Discover the latest on medical devices with press releases highlighting innovations, trends, and regulatory updates shaping the healthcare industry. Stay informed on key developments in medical device design and explore opportunities in patient care solutions.

May 8, 2026 at 11:18 AM

Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced that SkinCure Oncology and Sensus Healthcare have amicably resolved their dispute and are moving forward constructively with a shared commitment to patient care and clinical excellence. In March 2026, Sensus Healthcare filed a lawsuit in the Circuit Court for the Fifteenth Judicial Cir...
May 8, 2026 at 10:00 AM

Bruno Vision Care Wins 2026 MedTech Breakthrough Award

BOCA RATON, Fla.--(BUSINESS WIRE)--Bruno Vision Care's FDA-cleared Deseyne® Extended Depth of Focus daily disposable contact lens for presbyopia wins 2026 MedTech Breakthrough Award....
May 8, 2026 at 8:05 AM

Butterfly Network Appoints Caroll H. Neubauer to Board of Directors

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Caroll H. Neubauer to its Board of Directors, effective May 18, 2026. Mr. Neubauer will serve on the Board’s Compensation Committee and Technology Committee. Mr. Neubauer has achieved a distinguished career spanning three decades with B. Braun, including serving fo...
May 8, 2026 at 7:00 AM

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans to participate in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas, NV. Pulse Biosciences’ Management is scheduled to present on Wednesday, May 13, at 4:35 pm PT. A live and recorded webcast of the presentation will be available on the “Events Calendar and Presentations” page of the...
May 7, 2026 at 4:05 PM

Inogen Announces First Quarter 2026 Financial Results

BEVERLY, Mass.--(BUSINESS WIRE)--Inogen Announces First Quarter 2026 Financial Results...
May 7, 2026 at 4:05 PM

Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights included: Revenue of $3.4 million compared to $8.3 million for the three months ended March 31, 2025. Excluding sales to the Company’s historically largest customer, rev...
May 7, 2026 at 4:05 PM

Myomo Reports First Quarter 2026 Financial and Operating Results

BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2026. “Earlier this year we established four success pillars for 2026, including growing revenue from recurring patient sources, increasing market access, demonstrating operating leverag...
May 7, 2026 at 4:05 PM

Owlet Announces First Quarter 2026 Financial Results; Updates 2026 Guidance

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2026. Owlet’s President, Chief Executive Officer, and Co-Founder, Kurt Workman, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, May 7, 2026, at 4:30 p.m. ET. Q1 2026 Financial Highlights: Q1 Revenue of $22....
May 7, 2026 at 4:05 PM

Varex Announces Financial Results for Second Quarter Fiscal Year 2026

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter fiscal year 2026. Q2FY26 Summary Revenues $216 million GAAP gross margin 34% | Non-GAAP gross margin* 34% GAAP operating margin 7% | Non-GAAP operating margin* 9% GAAP net loss $0.19 per diluted share | Non-GAAP net income* $0.21 per diluted share Cash outflows from operations of $2 million "Demand remained solid in the second quarter, with continued m...
May 7, 2026 at 4:05 PM

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed financial guidance for the year ending December 31, 2026. First Quarter 2026 Financial and Strategic Highlights Achieved record first quarter pump shipments, sales and gross margin: Shipments of more than 29,000 pumps worldwide, including 19,000 pumps in the United States Sales o...
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up